338
Participants
Start Date
January 1, 2015
Primary Completion Date
December 1, 2024
Study Completion Date
December 1, 2024
initial Sequential iRT
"For unresectable locally advanced NSCLC, definitive thoracic radiotherapy must have been administered as the initial treatment, with immunotherapy initiated within 90 days after RT.~For de novo metastatic NSCLC, radiotherapy targeting the primary lung tumor or metastatic lesions must have been administered as the initial treatment, with immunotherapy initiated within 90 days."
initial Concurrent iRT
"For unresectable locally advanced NSCLC, definitive thoracic radiotherapy must have been administered as the initial treatment, with immunotherapy concurrently with RT.~For de novo metastatic NSCLC, radiotherapy targeting the primary lung tumor or metastatic lesions must have been administered as the initial treatment, with immunotherapy concurrently with RT."
RT with maintenance of ICI
For post-treatment progressive NSCLC, salvage radiotherapy performed during immunotherapy.
RT after discontinuation of ICI
For post-treatment progressive NSCLC, salvage radiotherapy performed during within 90 days after the cessation of immunotherapy.
Queen Mary Hospital, Hong Kong
Fengming Kong
OTHER